ArticlePloS one2009

Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.

Barbara Wegiel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.